dsm-firmenich Animal Nutrition & Health

Background

dsm-firmenich Animal Nutrition & Health (ANH) was a global leader in providing science-based solutions for animal nutrition and health. The business offered a comprehensive portfolio, including vitamins, premixes, feed additives, and precision services, aimed at enhancing animal health, performance, feed efficiency, and sustainability across livestock production. Its mission was to deliver high-quality animal protein while reducing environmental impact. In 2025, ANH generated annualized net sales of approximately €3.5 billion and employed around 8,000 people worldwide.

Key Strategic Focus

ANH's strategic focus encompassed several key areas:

Core Objectives: To improve farm productivity while reducing environmental impact, enhance animal and human health with nutritious and affordable protein, and unlock consumer delight through aroma science.

Areas of Specialization: The business specialized in essential products, premix, performance solutions, precision services, and aroma.

Key Technologies Utilized: ANH leveraged cutting-edge AI-driven precision services, feed enzymes, eubiotics, mycotoxin deactivators, and AI for livestock management to enhance livestock health and performance.

Primary Markets Targeted: The company served a global market, providing solutions to animal farmers worldwide to meet the growing demand for healthy and sustainable proteins.

Financials and Funding

In 2025, ANH reported annualized net sales of approximately €3.5 billion. The company underwent significant financial restructuring, including the divestment of its Feed Enzymes activities to Novonesis for €1.5 billion in 2025. In February 2026, dsm-firmenich announced an agreement to divest the remaining ANH business to CVC Capital Partners for an enterprise value of about €2.2 billion, which includes an earnout of up to €0.5 billion. dsm-firmenich retained a 20% equity stake in the divested ANH companies.

Pipeline Development

ANH's product pipeline included several notable candidates:

Bovaer®: A methane-reducing feed additive designed to decrease methane emissions from cattle. Approved by the U.S. FDA in May 2024, Bovaer® was shown to reduce methane emissions by about 30% in dairy cows and 45% in beef cattle.

Veramaris™: A joint venture with Evonik Industries producing an algae-based alternative to fish oil, contributing to sustainable aquaculture practices.

Technological Platform and Innovation

ANH distinguished itself through several technological platforms and innovations:

Proprietary Technologies: The company developed advanced feed additives, including feed enzymes, eubiotics, and mycotoxin deactivators, to enhance animal health and performance.

Significant Scientific Methods: ANH utilized AI-driven precision services for livestock management, enabling data-driven decision-making to improve farm productivity and sustainability.

Leadership Team

As of the latest available information, specific details about the leadership team of ANH were not publicly disclosed.

Leadership Changes

In February 2026, dsm-firmenich announced the divestment of ANH to CVC Capital Partners, marking a significant strategic shift. This transaction was expected to close by the end of 2026, subject to regulatory approvals and employee consultation processes.

Competitor Profile

Market Insights and Dynamics

The global animal nutrition and health market is characterized by increasing demand for sustainable and efficient livestock production. Key trends include the adoption of precision nutrition, emphasis on animal welfare, and the development of products that reduce environmental impact, such as methane-reducing feed additives.

Competitor Analysis

ANH's primary competitors included:

Cargill Animal Nutrition: A leading provider of animal nutrition products and services, offering a wide range of feed additives and premixes.

Archer Daniels Midland (ADM) Animal Nutrition: A global player in animal nutrition, supplying feed ingredients and premixes to enhance animal health and performance.

Evonik Industries: A competitor in the production of feed additives and amino acids, with a focus on sustainable animal nutrition solutions.

Strategic Collaborations and Partnerships

ANH engaged in strategic collaborations to enhance its market position:

Joint Ventures: The company formed Veramaris™, a joint venture with Evonik Industries, to produce an algae-based alternative to fish oil, supporting sustainable aquaculture practices.

Supply Agreements: ANH entered into long-term supply agreements to ensure continuity and security in human and pet food applications.

Operational Insights

ANH's strategic considerations included:

Market Position: As a global leader in animal nutrition and health, ANH maintained a strong market presence through its comprehensive product portfolio and innovative solutions.

Competitive Advantages: The company's focus on sustainability, precision nutrition, and AI-driven services provided a competitive edge in addressing the evolving needs of the animal farming industry.